Zoetis Inc. (ZTS) Revenue by Segment
Zoetis revenue by segment at a glance
In Q2 fiscal 2026 (the quarter ended June 30, 2026), Zoetis's largest business segment was United States, with $1.27 billion or 52% of revenue, down 6.6% from a year earlier. Next: International (48%).
By product or service, Parasiticides brought in 28%, Dermatology brought in 16% and Cattle brought in 16% of revenue in Q2 fiscal 2026.
By region, Total Geographical Area brought in 99% and Chile brought in 1% of revenue in Q2 fiscal 2026.
The fastest-growing business segment from a year earlier was International (+8.1%).
From company filings, in USD; latest quarter ended June 30, 2026; quarterly data from Q3 fiscal 2017.
Zoetis Inc.
Revenue breakdown
Fiscal quarters, from company filings
Zoetis revenue by business segment, last 4 quarters
| Business segment | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Share |
|---|---|---|---|---|---|
| United States | $1.3B | $1.1B | $1.3B | $1.4B | 52% |
| International | $1.2B | $1.1B | $1.1B | $1.1B | 48% |
In USD, fiscal quarters as reported; share = part of Q2 FY26 revenue.
Zoetis revenue by product or service, last 4 quarters
| Product or service | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Share |
|---|---|---|---|---|---|
| Parasiticides | $698.0M | – | – | – | 28% |
| Dermatology | $398.0M | $349.0M | $472.0M | $473.0M | 16% |
| Cattle | $390.0M | $392.0M | $399.0M | $323.0M | 16% |
| Anti-infective Products | $244.0M | $241.0M | $284.0M | $222.0M | 10% |
| Other Pharmaceuticals | $168.0M | $158.0M | $178.0M | $175.0M | 7% |
| Animal Health Diagnostics | $123.0M | $117.0M | $110.0M | $110.0M | 5% |
| Swine | $117.0M | $123.0M | $111.0M | $118.0M | 5% |
| Poultry | $115.0M | $118.0M | $106.0M | $104.0M | 5% |
| Fish | $83.0M | $66.0M | $78.0M | $81.0M | 3% |
| Other Non Pharmaceuticals | $70.0M | $66.0M | $64.0M | – | 3% |
In USD, fiscal quarters as reported; share = part of Q2 FY26 revenue.
Zoetis revenue by region, last 4 quarters
| Region | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Share |
|---|---|---|---|---|---|
| Total Geographical Area | $2.4B | $2.2B | $2.4B | $2.4B | 99% |
| Chile | $34.0M | – | $29.0M | $34.0M | 1% |
In USD, fiscal quarters as reported; share = part of Q2 FY26 revenue.
Questions and answers
What are Zoetis's business segments?
United States and International (as reported for Q2 fiscal 2026).
Which business segment makes the most money for Zoetis?
United States: $1.27 billion, or 52% of revenue, in Q2 fiscal 2026.
What are Zoetis's main products and services?
By revenue in Q2 fiscal 2026: Parasiticides (28%), Dermatology (16%), Cattle (16%) and Anti-infective Products (10%).
Where does Zoetis make its money?
By region in Q2 fiscal 2026: Total Geographical Area (99%) and Chile (1%).
